Changes in Personal Protective Equipment Usage Among Healthcare Personnel From the Beginning of Pandemic to Intra-COVID-19 Pandemic in Thailand.


Journal

Annals of work exposures and health
ISSN: 2398-7316
Titre abrégé: Ann Work Expo Health
Pays: England
ID NLM: 101698454

Informations de publication

Date de publication:
06 06 2023
Historique:
received: 21 12 2022
accepted: 06 03 2023
medline: 8 6 2023
pubmed: 2 5 2023
entrez: 2 5 2023
Statut: ppublish

Résumé

Personal protective equipment (PPE) use is associated with reduced risk of SARS-CoV-2 infection among healthcare personnel (HCP). There are limited data on the impact of the novel coronavirus disease 2019 (COVID-19) pandemic on the PPE use of HCP. We describe the changes in PPE use from just before the widespread of community outbreaks ('pre-pandemic') to intra-pandemic time points, and examine factors associated with not changing in PPE use behavior among HCP in four Thai hospitals. We performed a retrospective cohort evaluation using two-time points: (i) February-March 2020 (pre-pandemic period); and (ii) January-March 2021 (intra-pandemic period). Self-reported frequency of appropriate PPE use was measured by a Likert scale. We used multivariable logistic regression to identify factors associated with no increase in self-reported PPE use. Of 343 HCP, the proportion of participants reporting 'always' using PPE rose from 66% during the pre-pandemic period to 80% during the pandemic. Factors associated with HCP who did not increase in PPE use included having high baseline reported PPE, being a non-registered HCP (e.g. nurse assistants, dental assistants, porters), being male, and having a low perceived risk of becoming infected with any respiratory virus while working in the hospital. PPE education, training, and risk communication content should target all cadres of HCP, regardless of registered/non-registered status, with a focus on behavior change for improved prevention and control of SARS-CoV-2 and other respiratory viruses in healthcare settings.

Identifiants

pubmed: 37129889
pii: 7147884
doi: 10.1093/annweh/wxad015
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

637-649

Subventions

Organisme : CGH CDC HHS
ID : U01 GH000152
Pays : United States

Informations de copyright

Published by Oxford University Press on behalf of The British Occupational Hygiene Society 2023.

Auteurs

Chayanit Mahasing (C)

Division of Epidemiology, Department of Disease Control, Ministry of Public Health, Nonthaburi 11000, Thailand.

Wanitchaya Kittikraisak (W)

Influenza Program, Thailand Ministry of Public Health-U.S. Centers for Disease Control and Prevention Collaboration, Nonthaburi 11000, Thailand.

Joshua A Mott (JA)

Influenza Program, Thailand Ministry of Public Health-U.S. Centers for Disease Control and Prevention Collaboration, Nonthaburi 11000, Thailand.
Influenza Division, U.S. Centers for Disease Control and Prevention, Georgia 30329, USA.

Pornsak Yoocharoen (P)

Department of Disease Control, Ministry of Public Health, Nonthaburi 11000, Thailand.

Phunlerd Piyaraj (P)

Parasitology Department, Phramongkutklao College of Medicine, Bangkok 10400, Thailand.

Chuleekorn Tanathitikorn (C)

Department of Disease Control, Ministry of Public Health, Nonthaburi 11000, Thailand.

Somsak Punjasamanvong (S)

Internal Medicine Department, Rayong Hospital, Rayong 21000, Thailand.

Thanapat Wongrapee (T)

Internal Medicine Department, Phaholpolpayuhasena Hospital, Kanchanaburi 71000, Thailand.

Patama Suttha (P)

Internal Medicine Department, Bamrasnaradura Infectious Diseases Institute, Nonthaburi 11000, Thailand.

Thanit Rattanathumsakul (T)

Division of Epidemiology, Department of Disease Control, Ministry of Public Health, Nonthaburi 11000, Thailand.

William W Davis (WW)

Influenza Program, Thailand Ministry of Public Health-U.S. Centers for Disease Control and Prevention Collaboration, Nonthaburi 11000, Thailand.
Influenza Division, U.S. Centers for Disease Control and Prevention, Georgia 30329, USA.

Matthew Westercamp (M)

Division of Healthcare Quality Promotion, U.S. Centers for Disease Control and Prevention, Georgia 30329, USA.

Suthat Chottanapund (S)

Department of Disease Control, Ministry of Public Health, Nonthaburi 11000, Thailand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH